SCAI issues expert consensus on managing patients with out of hospital cardiac arrest
(Society for Cardiovascular Angiography and Interventions) The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement describing recommendations for the management of patients with out-of-hospital cardiac arrest (OHCA). The statement, published today in Catheterization and Cardiovascular Interventions, was presented during the SCAI 2020 Scientific Sessions Virtual Conference. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 14, 2020 Category: International Medicine & Public Health Source Type: news

Patients with intermediate left main disease experience worse cardiovascular events
(Society for Cardiovascular Angiography and Interventions) A new study shows that when compared with patients without intermediate left main coronary artery disease, those with intermediate left main disease have greater risk of cardiovascular events. The findings of the ISCHEMIA trial sub study were presented during the SCAI 2020 Scientific Sessions Virtual Conference as featured clinical research. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 14, 2020 Category: International Medicine & Public Health Source Type: news

Many Transcatheter Valve Interventions Can Wait Until After COVID-19 Pandemic: Societies Many Transcatheter Valve Interventions Can Wait Until After COVID-19 Pandemic: Societies
Most transcatheter mitral-valve repairs (TMVRs) and many transcatheter aortic-valve replacements (TAVRs) can be delayed until the COVID-19 pandemic is over, according to a consensus statement from the American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI).Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 21, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news

SCAI, ACC, and ACEP release consensus on managing AMI patients during COVID-19
(Society for Cardiovascular Angiography and Interventions) The Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC) and American College of Emergency Physicians (ACEP) have released a consensus statement that provides recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the coronavirus disease-2019 (COVID-19) pandemic. The document is jointly published in Catheterization and Cardiovascular Interventions, the official journal of SCAI, and the Journal of the American College of Cardiology. (Source: EurekAlert! - In...
Source: EurekAlert! - Infectious and Emerging Diseases - April 21, 2020 Category: Infectious Diseases Source Type: news

SCAI issues guidance on cardiac interventions
The Society for Cardiovascular Angiography and Interventions (SCAI) has released...Read more on AuntMinnie.comRelated Reading: 3D fusion improves CT, MRI heart disease diagnosis AI speeds up reconstruction of 4D flow MRI MRI parameters are safe for implanted cardiac devices NorthStar licenses fibrin-targeted cardiac SPECT agent (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 20, 2020 Category: Radiology Source Type: news

Differences in Microaneurysm Detection Technologies Affect Diabetic Retinopathy Grading Differences in Microaneurysm Detection Technologies Affect Diabetic Retinopathy Grading
In eyes with diabetic retinopathy (DR), microaneurysm detection varies between ultrawide field color imaging and ultrawide field fluorescein angiography, potentially affecting assessments of DR severity, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 17, 2020 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Medtech in a Minute: CGMs Join War on COVID-19, and More
CGMs Join the COVID-19 Fight In response to healthcare workers asking for safer ways to monitor hospitalized diabetes patients with COVID-19, FDA is allowing both Dexcom and Abbott to supply continuous glucose monitoring (CGM) systems for use in the hospital setting during the pandemic. This allows frontline healthcare workers in hospitals to remotely monitor patients with diabetes in order to minimize exposure to the virus that causes COVID-19 and preserve use of personal protective equipment. Read more about medtech's response to the global pandemic on our COVID-19 News Central page.   Boston Scientific Recal...
Source: MDDI - April 10, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Source Type: news

Mayo Clinic offers guidance on treating COVID-19 patients with signs of acute heart attack
(Mayo Clinic) Much remains unknown about COVID-19, but many studies already have indicated that people with cardiovascular disease are at greater risk of COVID-19. There also have been reports of ST-segment elevation (STE), a signal of obstructive coronary artery disease, in patients with COVID-19 who after invasive coronary angiography show no sign of the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2020 Category: International Medicine & Public Health Source Type: news

Mayo Clinic experts offer guidance on treating COVID-19 patients with signs of acute heart attack
ROCHESTER, Minn. -- Much remains unknown about COVID-19, but many studies already have indicated that people with cardiovascular disease are at greater risk of being susceptible to COVID-19. There also have been reports of ST-segment elevation (STE), a signal of obstructive coronary artery disease, in patients with COVID-19 who after invasive coronary angiography show no [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - April 8, 2020 Category: Hospital Management Source Type: news

Boston Scientific Recalls Angiographic Catheters Due to Injuries
At least nine people have been injured by a faulty cateter tip on Boston Scientific's Imager II 5F Angiographic Catheters, FDA reported this week. The company initiated a recall of the device in February that includes 6,130 of the catheters distributed between July 16, 2018 and Nov. 26, 2019. Click here for a full list of affected lot numbers. The catheters are used to provide a pathway to deliver contrast agents to blood vessels. FDA said there is a potential for the catheter tip to become detached during a patient procedure or during procedure preparation. According to the recall notice from FDA, use of the a...
Source: MDDI - April 7, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

FDA Class 1 Recall of Imager II Angiographic Catheters FDA Class 1 Recall of Imager II Angiographic Catheters
Boston Scientific ' s Imager II 5F angiographic catheters have been recalled because the catheter tip may become detached during a patient procedure or during procedure prep.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2020 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Today, the @US_FDA identified a Class I Recall, the most serious type of recall: Boston Scientific Corporation Recalls Imager II Angiographic Catheters Due to Tip Detachment.pic.twitter.com/QP2jFE7FoX
Today, the @US_FDA identified a Class I Recall, the most serious type of recall: Boston Scientific Corporation Recalls Imager II Angiographic Catheters Due to Tip Detachment. pic.twitter.com/QP2jFE7FoX (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - April 7, 2020 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

Contrast-Induced Kidney Injury Risk Low in CKD Contrast-Induced Kidney Injury Risk Low in CKD
Contrast-induced kidney damage can occur after angiography in patients with chronic kidney disease, but the actual risk appears low and new data suggest it may be prevented by a novel drug.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Cath and COVID-19: SCAI President on Handling STEMI, NSTEMI Cath and COVID-19: SCAI President on Handling STEMI, NSTEMI
Thrombolysis or PCI for STEMI? Hard data is scarce, but the Cardiovascular Angiography and Interventions leader offers informal recommendations for handling patients in need of cardiac catheterization.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 16, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Kinepict gets FDA clearance for angiography software
Hungarian medical software developer Kinepict Health has garnered U.S. Food...Read more on AuntMinnie.com (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 10, 2020 Category: Radiology Source Type: news